| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 04/18/2006 | US7030196 Process for reducing the molecular weight of polypropylene |
| 04/18/2006 | US7030150 Benzimidazole compounds and antiviral uses thereof |
| 04/18/2006 | US7030144 Central nervous system disorders |
| 04/18/2006 | US7030141 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 04/18/2006 | US7030140 such as 1-[1-(N,N-dimethyl-aminoethyl)-1H-benzimidazol-2-ylmethyl]-1H-benzotriazole hydrochloride for treatment of respiratory syncytial virus |
| 04/18/2006 | US7030139 Compounds |
| 04/18/2006 | US7030138 Benzamidine derivatives |
| 04/18/2006 | US7030134 such as N-cyclopentyl-2-(4-fluorophenyl)-3-[2-(1-pyrrolidinyl)-4-pyrimidinyl]-6-(trifluoromethyl)pyrazolo[1,5-a]pyridin-7-amine; for treatment of herpes viral infections |
| 04/18/2006 | US7030130 Benzofuran derivatives and their use as antibacterial agents |
| 04/18/2006 | US7030125 useful in the treatment of TGF- beta related disease states including, for example, cancer and fibrotic diseases |
| 04/18/2006 | US7030124 Method of treating depression with delta receptor agonist compounds |
| 04/18/2006 | US7030122 1,4-disubstituted piperazine ligands for neurotransmitter receptors |
| 04/18/2006 | US7030113 Aminobenzimidazoles as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 04/18/2006 | US7030063 Cyclohexenonquinolinoyl-derivatives as herbicidal agents |
| 04/18/2006 | US7029835 Photothermographic element comprising improved base precursors and methods for their use |
| 04/18/2006 | US7029654 anticoagulants either embedded in or physically linked to materials used in the manufacture of devices used in blood collection, blood circulation, and blood storage |
| 04/13/2006 | WO2006039243A1 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 04/13/2006 | WO2006039215A2 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 04/13/2006 | WO2006038989A1 Substituted arylamides |
| 04/13/2006 | WO2006038738A1 Receptor function regulating agent |
| 04/13/2006 | WO2006038680A1 2-arylcarboxamide-nitrogeneous heterocycle compound |
| 04/13/2006 | WO2006038111A1 Benzoimidazole derivatives useful as antiproliferative agents |
| 04/13/2006 | WO2006038041A1 Besylate salts of six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain |
| 04/13/2006 | WO2006038006A2 5-sulfonyl-1-piperidinyl substituted indole derivatives as 5-ht6 receptor antagonists for the treatment of cns disorders |
| 04/13/2006 | WO2006037950A1 Method of deprotection |
| 04/13/2006 | WO2006028958A3 Pyridyl inhibitors of hedgehog signalling |
| 04/13/2006 | WO2006010546A3 Aryl-pyridine derivatives as 11-beta-hsd1 inhibitors |
| 04/13/2006 | WO2006007540A3 Piperidine derivatives as nk1 antagonists |
| 04/13/2006 | WO2005116027A3 Indazole and indolone derivatives and their use as pharmaceuticals |
| 04/13/2006 | WO2005110416A3 4,5-disubstituted-2-aryl pyrimidines |
| 04/13/2006 | WO2005082866A3 Substituted 1, 2, 4- triazole derivatives as oxytocin antagonists |
| 04/13/2006 | WO2005049559A3 Novel piperidine-substituted indoles- or hetero-derivatives thereof and their use as modulators of chemokine receptor (ccr-3) |
| 04/13/2006 | WO2005007621A3 Ubiquitin ligase inhibitors |
| 04/13/2006 | US20060079707 Cyclization by reacting 4-(2-CHLORO-4-TRIFLUOROMETHYL-PHENYL)-4-CYANO-BUT-3-ENOIC ACID METHYL ESTER in the presence of a palladium catalyst and a base; chemical intermediates for preparing 10-AZA-TRICYCLO[6.3.1.02,7] drugs; bind nicotinic acetylcholine receptor, modulate cholinergic function |
| 04/13/2006 | US20060079688 Process for producing acid adduct salt of polyacidic base compound |
| 04/13/2006 | US20060079685 1-(4-Bromo-benzyl)-4-(4-isopropyl-phenyl)-6-propargyloxy-1H-quinazolin-2-one;osteoporosis, bone disorders, fractures, osteopathy, osteo-malacia, periodontal bone loss or bone loss due to arthritis or osteoarthritis; for promoting the release of parathyroid hormone |
| 04/13/2006 | US20060079683 Arylthiobenzylpiperidine derivatives |
| 04/13/2006 | US20060079561 Insecticidal anthranilamides |
| 04/13/2006 | US20060079560 Crystalline form of omeprazole |
| 04/13/2006 | US20060079559 S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine and other dermal anesthetics |
| 04/13/2006 | US20060079558 R-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine and other dermal anesthetics |
| 04/13/2006 | US20060079556 metabolic and eating disorders, improvement of cognitive function, substance abuse disorders, cognitive disorders, autoimmune glomerulonephritis |
| 04/13/2006 | US20060079553 Quinoline derivatives as glucokinase ligands |
| 04/13/2006 | US20060079552 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea salt |
| 04/13/2006 | US20060079546 Aminopiperidine derivatives as antibacterials |
| 04/13/2006 | US20060079523 N-[3-(1-{[4-(4-fluorophenylthio)phenyl]methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide; melatonin-concentrating hormone (MCH1) receptor ligand; antidepressant, anxiolytic, antidiabetic agent |
| 04/13/2006 | US20060079519 Heterocyclic-substituted benzamide derivatives, e.g., benzyl [2-(4-{1-[5-(5-tert-Butyl-3-methanesulfonylamino-2-methoxy-phenylcarbamoyl)-2-methyl-phenyl]-1H-1,2,3-triazol-4-yl}-2-phenyl-2H-pyrazol-3-yl)-ethyl]-carbamate; inhibit production of cytokines; useful for treating chronic inflammatory disease. |
| 04/13/2006 | US20060079518 Such as (S)-4-[2-(3-Chloro-phenyl)-2-hydroxy-ethylamino]-3-{6-[4-(2-methoxy-ethyl)-piperazin-1-yl]-4-methyl-1H-benzimidazol-2-yl}-1H-pyridin-2-one bis hydrochloride; anticancer agents; antiproliferative agents |
| 04/13/2006 | US20060079498 ((2S,4S)-4-(4-(3-(Trifluoromethyl)phenyl)piperazin-1-yl)pyrrolidin-2-yl)-(3,3-difluoropyrrolidin-1-yl)-methanone dihydrochloride; dipeptidyl peptidase-IV inhibitor; diabetic complications including diabetic neuropathy, diabetic nephropathy, diabetic microangiopathy |
| 04/13/2006 | US20060079489 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine |
| 04/13/2006 | US20060078760 Cyclometalated transition metal complex and organic electroluminescent display device using the same |
| 04/13/2006 | DE102004047254A1 Carbonylverbindungen Carbonyl compounds |
| 04/13/2006 | CA2583326A1 Receptor function regulating agent |
| 04/13/2006 | CA2583287A1 5-sulfonyl-1-piperidinyl substituted indole derivatives as 5-ht6 receptor antagonists for the treatment of cns disorders |
| 04/13/2006 | CA2582356A1 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 04/13/2006 | CA2582347A1 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 04/13/2006 | CA2582327A1 2-arylcarboxamide-nitrogeneous heterocycle compound |
| 04/12/2006 | EP1645558A1 Piperazinylpyrazines as serotonin 5-HT2C receptor modulators |
| 04/12/2006 | EP1644372A2 Substituted quinolin-4-ylamine analogues |
| 04/12/2006 | EP1644370A2 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 04/12/2006 | EP1644369A2 Arylamine-substituted quinazolinone compounds |
| 04/12/2006 | EP1644365A2 Pyrazine and pyridine derivatives as rho kinase inhibitors |
| 04/12/2006 | EP1644361A1 Chinazoline derivatives as aurora kinase inhibitors |
| 04/12/2006 | EP1644359A2 Metabolites of tricyclic amides useful for inhibition of g-protein function and methods of treatment of proliferative diseases |
| 04/12/2006 | EP1644358A2 Biaryl piperazinyl-pyridine analogues |
| 04/12/2006 | EP1644357A1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 04/12/2006 | EP1644356A1 Substituted 4-amino-1-benzylpiperidine compounds |
| 04/12/2006 | EP1644355A1 Bicyclic indolyl derivatives and methods of their use as serotonergic agents |
| 04/12/2006 | EP1644354A1 3-pyridylcarboxamide derivatives as pesticidal agents |
| 04/12/2006 | EP1644353A1 Amide-substituted 1,2,4-triazin-5(2h)-ones for the treatment of chronically inflammatory diseases |
| 04/12/2006 | EP1644352A1 Process for preparing isomerically pure prodrugs of proton pump inhibitors |
| 04/12/2006 | EP1644351A1 Imidazole derivatives iii |
| 04/12/2006 | EP1644343A1 5-substituted quinazolinone derivatives |
| 04/12/2006 | EP1644340A1 N-{'4-substituted piperazine-1-sulfonylmethyl]alkyl}-n-hydroxyformamide compounds as metalloproteinase inhibitors |
| 04/12/2006 | EP1644339A1 6-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors |
| 04/12/2006 | EP1644338A1 2, 4, 6-trisubstituted pyrimidine derivatives useful for the treatment of neoplastic and autoimmune diseases |
| 04/12/2006 | EP1644337A1 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 04/12/2006 | EP1644336A1 Nitrogen-containing heteroaryl compounds and their use in increasing endogeneous erythropoietin |
| 04/12/2006 | EP1644335A1 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 04/12/2006 | EP1644334A1 Antithrombotic ethers |
| 04/12/2006 | EP1644322A1 Aspartyl protease inhibitors |
| 04/12/2006 | EP1643998A1 Dual nk1/nk3 antagonists for treating schizophrenia |
| 04/12/2006 | EP1643991A1 Benzimidazole carboxamides as raf kinase inhibitors |
| 04/12/2006 | EP1643989A1 Cis-imidazolines as mdm2 inhibitors |
| 04/12/2006 | EP1643988A1 Substituted pyrrole derivatives as hmg-coa reductase inhibitors |
| 04/12/2006 | EP1643986A2 Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer s disease |
| 04/12/2006 | EP1643960A2 Arylsulfonamide derivatives |
| 04/12/2006 | EP1542988B1 Piperidine quinolyl propyl derivatives, preparation method and intermediates and compositions containing same |
| 04/12/2006 | EP1476444B1 Heterocyclic compounds possessing affinity at 5ht1-type receptors and use thereof in therapy |
| 04/12/2006 | EP1401828B1 N-formyl hydroxylamine compounds as inhibitors of pdf |
| 04/12/2006 | EP1345920B1 Novel sulfamides and their use as endothelin receptor antagonists |
| 04/12/2006 | EP1336605B1 Substituted phenol derivatives or salts thereof as inhibitors of coagulation factor x |
| 04/12/2006 | EP1311499B1 Bicyclic compounds as h3 receptor ligands |
| 04/12/2006 | EP1254119B1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 04/12/2006 | EP1005356B1 Novel antibacterial agents |
| 04/12/2006 | EP1003736B1 Substituted 4-benzoyl-pyrazoles |
| 04/12/2006 | EP0843549B1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a 4 hydrolase inhibitor |
| 04/12/2006 | CN1759114A Heterocyclic N-aryl carboxamides as cytokine inhibitors |
| 04/12/2006 | CN1759111A Imidazol-4-yl-ethynyl-pyridine derivatives |
| 04/12/2006 | CN1759110A Pyrazole derivative |